What the headlong fall of 23andMe signals for India’s genetic-testing market
Synopsis
23andMe, a pioneer in genetic testing, struggles to maintain its early success. As quickly as it soared, its market value plummeted, leaving the company’s future uncertain. ET Prime examines the challenges faced by 23andMe, along with opportunities and potential implications for India’s genetic-testing market.
Unravelling precise family history and ancestry by simple at-home saliva tests zoomed 23andMe into the living rooms of millions of people in the US. However, once a pioneer, the company finds itself in a dramatic decline. As quickly as it soared, the market value for 23andMe plummeted, and the future of the company now hangs in the balance. Anne Wojcicki, CEO and founder of 23andMe, announced on November 12 that the company has “substantial
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Refer & Earn
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
